baber/WOPTO huggingface dataset:
Patent PT-1241109-E (PT)
Title: Pallet container
Inventor: CHEVILOTTE JEROME EMMANUEL
IPC: B65D77/06
Filed: 2002-03-15
Abstract: Pallet container (1) comprising a bottle (2), an enclosure (5) for said bottle as well as a plastic pallet (6). The enclosure, preferably comprising a grid (5) is connected to a plastic pallet by having its lower horizontal circumconferential rod (9) received in a laterally opening circumferential groove (10) in the plastic pallet. The rod can be locked through the use of a side plate (12). <IMAGE>
Patent PT-1416937-E (PT)
Title: Prophylactic and therapeutic use of hydroxysteroids
Inventor: WUELFERT ERNST
IPC: A61P9/10
Filed: 2002-08-13
Abstract: 3-Hydroxy-7-hydroxy steroids and 3-oxo-7-hydroxy steroids, especially the 7β-isomers thereof, and pharmaceutically acceptable esters thereof are useful for protection against ischaemia-induced damage to peripheral organs, such as the heart or kidneys, as well as treatment of spiral cord injury.
Patent PT-1392599-E (PT)
Title: Method for producing an essentially chlorite-free, stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
Inventor: POLAK WALTER
IPC: C02F1/76
Filed: 2002-06-05
Abstract: The invention relates to a method for producing an essentially chlorite-free, stable, aqueous chlorine-oxygen solution. Said method comprises the following steps: (1) a hydrogen sulfate compound is dissolved in water, (2) an acid is added to the aqueous solution containing hydrogen sulfate in such a quantity that the pH value in the target final product in the form of the essentially chlorite-free, stable, aqueous chlorine-oxygen solution is maintained between approximately 3 and 5; (3) a peroxide compound is added; and (4) an aqueous chlorite solution is added dropwise in a quantity of between approximately 60 and 90 mole %, especially between 70 and 80 mole %, of chlorite, in relation to the concentration of peroxide compound. The invention also relates to the chlorine-oxygen solutions which can be obtained by means of said method.
Patent PT-1545609-E (PT)
Title: Antibodies directed against oxidised apolipoprotein b
Inventor: NILSSON JAN
IPC: A61K39/395
Filed: 2003-10-06
Abstract: The present invention relates to passive immunization for treating or preventing atherosclerosis using an isolated human antibody directed towards at least one oxidized fragment of apolipoprotein B in the manufacture of a pharmaceutical composition for therapeutical of prophylactical treatment of atherosclerosis by means of passive immunization, as well as method for preparing such antibodies, and a method for treating a mammal, preferably a human using such an antibody to provide for passive immunization.
Patent PT-1449664-E (PT)
Title: Liquid storage unit and liquid ejecting apparatus
Inventor: KIMURA HITOTOSHI
IPC: B41J2/175
Filed: 2004-02-19
Abstract: The invention provides a liquid storage unit comprising a case (50a), a liquid storage part (50f) which is provided in the case arid in which a liquid is stored, a lead-out port (501) which leads out the liquid stored in the liquid storage part, wherein the liquid storage part includes an opening sealed by a flexible partitioning member (50e), a gas accommodation part (50g) with which a gas port (50k) communicates is formed between the flexible partitioning member and the case, and the liquid stored in the liquid storage part is led to an outside through the lead-out port by a pressure of a gas introduced to the gas accommodation part from the gas port.
Patent PT-1668307-E (PT)
Title: Lance device with reciprocating drive
IPC: F28G1/16
Filed: 2004-08-13
Abstract: A lance device comprising a frame, guide and drive connected to the frame for moving the lance in the longitudinal direction relative to the frame. The drive of the lance is a reciprocating drive, allowing stepwise driving of the lance.
Patent PT-1586322-E (PT)
Title: Compositions comprising thalodimide and dexamethasone for the treatment of cancer& x9;
Inventor: D AMATO ROBERT J
IPC: A61K31/192
Filed: 1997-11-04
Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis and to treat disease states resulting from angiogenesis. Additionally, anti-inflammatory drugs, such as steroids and NSAIDs can inhibit angiogenesis dependent diseases either alone or in combination with thalidomide and related compounds. Importantly, these compounds can be administered orally.
Patent PT-1713036-E (PT)
Title: System for detecting incorrectly functioning sensors in a visitor counting system
Inventor: RUOHONEN JUHA
IPC: G07C9/00
Filed: 2005-04-11
Abstract: In a visitor counting system a plurality of sensors (107, 108, 109, 110) count the number of visitors passing by. A data-recording device (105, 106) connected to the sensors store records comprising the number of visitors counted within a predetermined time period. A remote visitor data processing unit (120) further comprises a record validation block for checking validity of the records, an interpolation block for creating new records to substitute the incorrect records, and a faulty-sensor detection block for concluding, based on the records, whether a sensor is faulty.
Patent PT-1717500-E (PT)
Title: Piezoelectric bending transducer
Inventor: WIRTL HANNES
IPC: H01L41/09
Filed: 2005-04-28
Abstract: The transducer (3) has plate-shaped flexible transducer element (4) formed with piezoelectrically activated working section and two wide sides. An electrical conductor structure (32) is formed on a flexible substrate (28) to form a flexible printed circuit (27) that electrical contacts work section of transducer element by piezoelectric activation. Part of the electrical conductor structure is formed within the region of the work section of the transducer element. Sensors (38,39) are provided in the work section of the transducer element and flexible printed circuit to detect change of state.
Patent PT-1888537-E (PT)
Title: Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
Inventor: SCHILS DIDIER PHILIPPE ROBERT
IPC: C07D239/46
Filed: 2006-05-24
Abstract: This invention relates to a process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)- amino]benzonitrile (I) starting from a 4-oxo-1,6-dihydro-pyrimidinylcarboxylic acid ester (II) or starting from a guanidine derivative which is reacted with an alkoxy-methylene malonic acid ester to an ester (II) which is converted to (I), which reaction sequence may be a one-pot procedure.
Patent PT-2165702-E (PT)
Title: Stable and readily dissolved compositions of candesartan cilexetil prepared with wet granulation
Inventor: GINDULLIS FRANK
IPC: A61K9/16
Filed: 2008-09-17
Abstract: The present invention relates to new pharmaceutical compositions in which Candesartan cilexetil is contained in a stabilized form with enhanced solubility and from which it is readily bioavailable when applied in conventional pharmaceutical dosage forms, and a process for the preparation of the same as well as of kits containing such compositions. The pharmaceutical compositions of Candesartan cilexetil or of its combinations with other active ingredients can be used in methods to treat subjects suffering from cardiovascular diseases.
Patent PT-2263688-E (PT)
Title: Neisseria meningitidis combination vaccines
Inventor: COSTANTINO PAOLO
IPC: A61K39/09
Filed: 2002-06-20
Abstract: The invention provides an immunogenic composition comprising a meningococcal serogroup A conjugate and a meningococcal serogroup C conjugate, and further comprising (i) an aluminium phosphate or an aluminium hydroxide adjuvant and (ii) a buffer.
Patent PT-508161-E (PT)
Inventor: SMITH WENDY A
IPC: A01H5/10
Filed: 1992-03-25
Abstract: This invention is directed to a screening method for the selection of mutations which confer acetohydroxyacid synthase (AHAS) inhibiting herbicide resistance to wheat. After mutagenesis of wheat seeds, the seeds are soaked in an AHAS inhibiting herbicide-containing solution containing a particular class of AHAS inhibiting herbicide. After planting, the soil containing the seeds is sprayed with an AHAS inhibiting herbicide of the same class as that used in the seed soak step prior to the emergence of the seedlings from the soil. Those wheat seedlings which emerge and are normal in appearance demonstrate resistance to the class of AHAS inhibiting herbicides used in the seed soak and spraying steps. This invention is also directed to the wheat selections and seeds identified by the screening method.
Patent PT-603887-E (PT)
Inventor: TAKEMURA MAKOTO
IPC: A61P31/04
Filed: 1993-12-23
Abstract: A compound represented by formula (I): <CHEM> wherein X<1> and X<2> each represent a halogen atom; R<1> represents a hydrogen atom or a substituent; R<2> represents a substituted or unsubstituted bicyclic heterocyclic substituent; A represents a nitrogen atom or a substituted carbon atom; and R represents a hydrogen atom or a substituent, or a salt thereof is disclosed. The compound exhibits potent antimicrobial activity and also high safety due to reduced lipophilicity.
Patent PT-672162-E (PT)
Inventor: BRINGI VENKATARAMAN
IPC: C12P17/02
Filed: 1993-02-22
Abstract: The present invention relates to a process for producing taxol and other taxanes in high yields from cell culture of Taxus species comprising: cultivating, in suspension culture in one or more nutrient media, cells derived from callus and/or suspension cultures of Taxus species, and recovering said taxol and other taxanes from said cells and/or said medium of said cell culture.
Patent PT-648112-E (PT)
Inventor: BROBERG FREDRIK
IPC: A61K47/10
Filed: 1993-06-24
Abstract: The present invention relates to an injectable solution for administration of one or more active compounds. According to the invention the active compound, which is in its neutral form, is dissolved in a biologically acceptable solvent whereby the active compound by administration precipitates, forming a solid phase of the solution in situ. Thus, said solution, which is easy to sterilize, is acting like a suspension when injected.
Patent PT-824323-E (PT)
Inventor: O'REILLY ROSEMARY ELIZABETH
IPC: A23L27/20
Filed: 1996-04-30
Abstract: PCT No. PCT/GB96/01028 Sec. 371 Date Oct. 16, 1997 Sec. 102(e) Date Oct. 16, 1997 PCT Filed Apr. 30, 1996 PCT Pub. No. WO96/34540 PCT Pub. Date Nov. 7, 1996Volatile flavour molecules having a particular cyclic enolone structure are stabilised by complexation with alkaline earth metal ions. These complexes are stable until exposed to certain conditions of temperature and/or moisture.
Patent PT-836396-E (PT)
Inventor: ROSSI FEDERICO
IPC: A45C11/22
Filed: 1996-05-08
Abstract: A watertight container, comprising a rigid watertight box connectable by a wrist strap to limbs or other members of a human or animal body, to permit carrying of an object contiguously and safely to an arm, a leg, or the neck, the object preferably being small size articles of value or utility or both particularly in situations of water immersion, engaging in sporting activities, and because of the watersealing feature of the box which is provided with suitable gaskets, seals to the anatomical suitability and the strength of the wrist strap housing the box.
Patent PT-974668-E (PT)
Inventor: LUTZ MONIKA
IPC: C12N7/01
Filed: 1999-07-01
Abstract: Described are recombinant adenoviral vectors retaining sufficient E4 sequences to improve the expression and/or persistence of expression of a gene of interest. Furthermore, the invention describes the use of a polynucleotide encoding one or more ORF(s) of the E4 region of an adenovirus selected from ORF1, ORF2, ORF3, ORF4, ORF3/4, ORF6/7, ORF6 and ORF7 taken individually or in combination, to improve the expression and/or persistence of expression of a gene of interest operably linked to regulatory elements and inserted into an expression vector. Finally, a host cell, a composition, an infectious viral particle comprising such a polynucleotide or adenoviral vector, a method for preparing said viral particle as well as their therapeutic use are described.
Patent PT-1114047-E (PT)
Inventor: CHEBIYYAM PRABHAKAR
IPC: C07D277/20
Filed: 1999-09-10
Abstract: An improved process for the preparation of 5-[4-[[3-Methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione of formula (1) which comprises: reducing the compound of formula (2') where R represents a (C1-C4)alkyl group using Raney Nickel or Magnesium in alcohol having 1 to 4 carbon atoms or mixtures thereof, if desired reesterifying using sufphuric acid at a temperature in the range of 0° C. to 60° C. to obtain a compound of formula (3') wherein R is as defined above, hydrolyzing the compound of formula (3') wherein R is as defined above, by conventional methods to obtain the acid of formula (4), condensing the acid of formula (4) with N-methyl anthranilamide directly without any preactivation of the acid to produce the compound of formula (1) and if desired, converting the compound of formula (1) to pharmaceutically acceptable salts thereof by conventional methods.
Patent PT-1104525-E (PT)
Inventor: BEAUJEAN JOSEPH MARIE ELISE
IPC: B65H75/40
Filed: 1999-08-17
Abstract: Method for preparing an elongated object (22) having a relatively high bending stiffness, such as an elongated tube or cable, before storing and/or transporting object, wherein a) the elongated object is provided with sufficient buoyancy capacity to enable the object to float on a liquid (14) with a predetermined specific gravity and that b) the elongated object (22), while floating on the liquid and carried thereby, is spirally wound into a flat monolayer spiral (36), the inner radius of which is preferably in the order of the diameter of the elongated body divided by the yield point (ratio) or larger of the most fracture critical material in the elongated object.
Patent SG-3890-G (SG)
Title: Garbage container to be emptied with the aid of vacuum
IPC: B65F5/00
Filed: 1990-01-16
Abstract: @ For emptying a garbage room in a multistory residential building, a garbage container (22) is placed in the garbage room, which container has a transport duct (31) between the lower portion (30) of the container and a garbage truck collection chamber, which can be evacuated to produce suction in the duct and thus move the garbage, usually in garbage bags. According to the invention, the garbage container is provided with an externally operable valve (25) at one inlet (23) for garbage coming from a garbage chute and an opening (32) for inlet of air, which opening is also provided with a sealable valve (33). For emptying, during a first evacuation phase, both valves (25 and 33) are closed and during a second evacuation phase, the valve (33) at the air intake (32) is open. The garbage bags are thus evacuated of air during the first evacuation phase and pressed together into a significantly smaller volume by the air flowing in during the second evacuation phase, at the same time as they are removed through the transport duct.
Patent SG-14086-G (SG)
Title: Method and apparatus for rotating an information storage disc
IPC: G11B19/24
Filed: 1986-02-15
Abstract: Method and apparatus for controllably rotating an information storage disc (11) relative to a radially movable optical transducer (15) whereby information is recorded on the disc in a series of substantially circular and concentrically arranged information tracks. The angular velocity of the disc and the radial velocity of the transducer are controllably adjusted to be inversely proportional to the radius of the particular information track being recorded, whereby the track is moved at a constant linear velocity relative to the transducer (15) and the successive tracks are equally spaced with respect to each other, and whereby a uniform information recording density over the surface of the disc is achieved.
Patent SG-67789-G (SG)
Title: Perfluoropolyether compositions which are soluble in non-fluorinated solvents
IPC: C08F283/06
Filed: 1989-10-04
Abstract: Polymeric compositions are provided in which perfluoropolyethers have been solubilized in non-fluorinated solvents by combining them with a solubilizing agent such as azotic conjugated compounds, and phosphorylated compounds. Typical of the perfluoropolyethers isTypical of the solubilizing agents is phosphorylated methacryloyloxyhydroxypropylisophthalate. The perfluoropolyether and the solubilizing agent are mixed to form a paste which is soluble in organic solvents such as methylethylketone. These compositions find utility as protective lubricant coatings for thin film magnetic recording media. They have the advantage that only one coating step is required in order to apply both the phosphorylated compound and the lubricating polyether. Recording media lubricated with these compositions have demonstrated excellent wear characteristics.
Patent IE-780048-L (IE)
Title: Treatment of whey.
IPC: C13K5/00
Filed: 1978-01-09
Abstract: PROCESS FOR THE PRODUCTION OF HIGH PROTEIN WHEY PRODUCTS of which the following is a specification. A process for the treatment of whey to produce products containing whey protein to a desired predetermined level. Whey is subjected to treatment for removing a portion of its lactose content by lactose crystallization and the resulting mother liquor, which has a protein level higher than that of the original whey, is then subjected to ultrafiltration carried out in such a controlled manner as to produce a protein rich fraction having the desired protein content. The process produces products standardized with respect to protein content, irrespective of variations in the protein level of the source whey, which may vary from time to time.
[CA1094868A]
Patent IE-820053-L (IE)
Title: Conference circuit for pcm system
IPC: H04Q11/04
Filed: 1982-01-13
Abstract: A conference circuit capable of controlling a plurality of conferences in PCM format. In this system, a person calling a party busy in a two party conversation and wishing to notify the called party of the call initiates camp-on service. The call is transferred to conference channels. The conference circuit performs a comparison between the loudness of the speech sample from each party in a conference to transmit the loudest sample for a second comparison. The second comparison is made against signals generated for providing camp-on tone to existing calls. The loudest sample output indicated by the second comparison is transmitted to the stations of the conference other than the one having generated the loudest signal.
[US4388717A]
Patent IE-890479-L (IE)
Title: Benzodioxoles
IPC: C07D231/16
Filed: 1989-02-15
Abstract: Novel benzodioxole derivative of the formula: <CHEM> wherein R<1> is a lower alkyl group, a lower alkoxy-lower alkyl group, phenyl group or pyridyl group, R<2> is hydrogen atom or a halogen atom and R<3> is hydrogen atom or a lower alkyl group, and a salt thereof are disclosed. Said derivative (I) and a salt thereof have potent diuretic, saluretic and uricosuric activities.
[EP0329326A1]
Patent IE-880540-L (IE)
Title: Anchor rod for a synthetic resin adhesive anchor
IPC: F16B13/14
Filed: 1988-02-26
Abstract: Anchoring bar (1), provided with a shaft (2) with several conical sections (7), cemented by means of a hydraulic mortar (12) in a borehole (11) made in a fixing foundation (10). When a crack appears, causing an increase in the diameter of the borehole (11), the mortar case expands, under the tractive force applied to the anchoring bar (1), as a result of a slippage of the anchoring bar (1) in relation to the hydraulic mortar (12). The outer surfaces of the conical sections (7) are therefore designed to be low in friction, provided with, for example, a coating, a film or a casing.
Patent IE-840680-L (IE)
Title: Radioaerosol delivery apparatus.
IPC: A61M15/02
Filed: 1984-03-20
Abstract: A radioaerosol delivery apparatus particularly adapted for the subsequent disposal of radioactively contaminated elements includes a manifold (88) for delivery of radioaerosol to a patient, having a pair of rigid conduits (100, 102) joined at one end to form a first connector (104) and at the other end to form a second connector (106). A third connector (116) is formed in the first conduit (100) between the first and second connectors and a one-way valve (112) is located between the first (104) and third (116) connector. A second one-way valve (114) is located in the second conduit (102) to permit exhalation by the patient. In use the manifold and source are located in a container incorporating radiation shielding. A portion (30) of the shielding is releasably attached to the manifold (88) and is removable from the container so as to carry with it the manifold (88) and source (82).
[EP0119864A2]
Patent IE-39211-L (IE)
Title: Pharmaceutical compositions containing pyrazolone¹derivatives
IPC: C07D231/20
Filed: 1974-04-17
Abstract: Pharmaceutical compositions useful for effecting diuresis and saluresis and for treating hypertension in humans and animals are produced by combining a pyrazol-5-one of the formula: <IMAGE> or a pharmaceutically acceptable nontoxic salt thereof wherein R is hydrogen, lower alkyl or amino; X is methylene, ethylene, methylene wherein 1 hydrogen atom is substituted by lower alkyl, or ethylene wherein 1 hydrogen atom is substituted by lower alkyl or 1 hydrogen atom on each of the two carbon atoms is substituted by lower alkyl; Y is a direct bond, oxygen or sulphur, provided that when X is methylene wherein 1 hydrogen atom is substituted by alkyl of 1 to 4 carbon atoms, Y is a direct bond; Z is aryl of 6 to 10 carbon atoms unsubstituted or substituted by: (a) 1 or 2 of the same or different substituents selected from the group consisting of halogen, trifluoromethyl, alkyl of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, and alkenoxy of 2 to 4 carbon atoms; (b) lower alkylamino, dilower alkylamino, trifluoromethoxy, nitro, cyano, carbamoyl, lower alkylcarbamoyl, dilower alkylcarbamoyl, sulphamyl,lower alkylsulphamyl, dilower alkylsulphamyl, -SOn-lower alkyl wherein n is 0, 1 or 2, or said dialkylamino, carbamoyl, alkylcarbamoyl, dialklycarbamoyl, sulphamyl, alkylsulphamyl, or dialkylsulphamyl, the nitrogen atom of which is a member of a 5-, 6- or 7-membered ring or said ring which additionally contains an oxygen atom; (c) lower alkylamino, dilower alkylamino, trifluoromethoxy, nitro, cyano, carbamoyl, lower alkylcarbamoyl, dilower alkylcarbamoyl, sulphamyl, lower alkylsulphamyl, dilower alkylsulphamyl, or -SOn-lower alkyl wherein n is 0, 1 or 2, and 1 or 2 substituents selected from the group consisting of alkyl of 1 to 4 carbon atoms, alkenyl of 2 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkenoxy of 2 to 4 carbon atoms, halogen and trifluoromethyl; or (d) a fused, saturated or unsaturated 5-, 6- or 7-membered ring or said ring additionally containing 1 or 2 oxygen or sulphur atoms, in combination with a pharmaceutically acceptable nontoxic inert diluent or carrier. The compositions are preferably administered orally or parenterally and in the latter case, sterile or isotonic aqueous solutions are preferred.
[US4288446A]
Patent IE-37035-L (IE)
Title: Internally coated cellulosic casing.
IPC: C08J7/04
Filed: 1972-06-09
Abstract: 1393301 Tubular casings UNION CARBIDE CORP 9 June 1972 [10 June 1971] 26961/72 Heading A2B A tubular cellulosic casing for encasing and processing food products, such as frankfurters, from which the skin has to be readily peeled, is internally coated with a homogeneous mixture of at least two components, one being a water-soluble cellulose ether in amount of at least 0.001 mg/in<SP>2</SP> of interior surface, and the other being selected from animal, vegetable, mineral or silicone oils and water-soluble alkylene oxide adducts of fatty acid partial esters, in amount of between 0.1 and 15 times the weight of the ether, and not more than 0.5 mg/in<SP>2</SP> of interior surface. A polyol of 3-6 carbon atoms may also be present.
[GB1393301A]